Case report: Temozolomide induced hypermutation: an indicator associated with immunotherapy response in patient with gliomas
BackgroundTemozolomide (TMZ) is a key component in the treatment of gliomas. Hypermutation induced by TMZ can be encountered in routine clinical practice, and its significance is progressively gaining recognition. However, the relationship between TMZ-…